{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T17:51:25Z","timestamp":1759773085882,"version":"3.37.3"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>This paper aimed to analyze the clinicopathological characteristics of invasive ductal carcinoma with an invasive micropapillary carcinoma component (IDC + IMPC), invasive ductal carcinoma with a ductal carcinoma in situ component (IDC + DCIS), and compare the clinicopathological characteristics and prognosis to those of IDC.<\/jats:p>\n            <jats:p>A total of 1713 patients (130 IDC + IMPC cases, 352 IDC + DCIS cases, and 1231 pure IDC cases) who underwent appropriate surgery from June 2011 to September 2017 were retrospectively selected.<\/jats:p>\n            <jats:p>Compared to the pure IDC and IDC + DCIS patients, the IDC + IMPC patients presented with more aggressive characteristics, such as a higher proportion of vascular invasion (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), fewer progesterone receptor (PR)-positive patients (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), a lower proportion of cases in American Joint Committee on Cancer stage I (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), a higher recurrence risk (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), more deaths (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), and more metastatic cases (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). Compared to the pure IDC and IDC + IMPC patients, the IDC+DCIS patients presented with less aggressive characteristics, such as a higher proportion of estrogen receptor-positive patients (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and PR-positive patients (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), a lower proportion of cases with nerve invasion (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and vascular invasion (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), a higher proportion of cases in American Joint Committee on Cancer stage I (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), fewer deaths (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001), and fewer metastatic cases (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). The patients with IDC + DCIS had significantly better disease-free survival (DFS) and overall survival (OS) compared to those with pure IDC and IDC + IMPC (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). The patients with IDC + IMPC had significantly worse DFS and OS compared to those with pure IDC and IDC + DCIS (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). In univariate analysis, the presence of an IMPC component in IDC (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.007), estrogen receptor status (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.05), and PR status (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.003) were factors associated with OS. In multivariate analysis, coexisting IMPC (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.04) was the only independent prognostic factor associated with OS.<\/jats:p>\n            <jats:p>Compared to IDC and IDC + DCIS, IDC + IMPC had more aggressive characteristics and significantly worse DFS and OS. Compared to IDC and IDC + IMPC, IDC + DCIS had less aggressive characteristics and significantly better DFS and OS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023487","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T21:57:44Z","timestamp":1607637464000},"page":"e23487","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2232-0465","authenticated-orcid":false,"given":"Xin","family":"Guan","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiying","family":"Xu","sequence":"additional","affiliation":[{"name":"The Second Breast Surgery Department of Jilin Cancer Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabin","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Hospital of Jilin University, Changchun, Jilin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Dong","sequence":"additional","affiliation":[{"name":"The Second Breast Surgery Department of Jilin Cancer Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2012","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer j Clin"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.5114\/aoms.2015.53964","article-title":"Retrospective evaluation of histopathological examinations in invasive ductal breast cancer of no special type: an analysis of 691 patients","volume":"13","author":"Badowska-Kozakiewicz","year":"2017","journal-title":"Arch Med Sci"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5114\/aoms.2012.31010","article-title":"Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in invasive breast cancer in women","volume":"9","author":"Badowska-Kozakiewicz","year":"2013","journal-title":"Arch Med Sci"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000350774","article-title":"A brief overview of the WHO classification of breast tumors","volume":"8","author":"Sinn","year":"2013","journal-title":"Breast Care"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0046-8177(99)90168-5","article-title":"Invasive micropapillary carcinoma of the breast: a prognostic study","volume":"30","author":"Paterakos","year":"1999","journal-title":"Hum Pathol"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/modpathol.3880399","article-title":"Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma","volume":"14","author":"Nassar","year":"2001","journal-title":"Mod Pathol"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02968297","article-title":"Clinical and pathologic features of invasive micropapillary carcinoma","volume":"11","author":"Kuroda","year":"2004","journal-title":"Breast Cancer"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1309\/XTJ7VHB49UD78X60","article-title":"Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior","volume":"121","author":"Pettinato","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1440-1827.2004.01590.x","article-title":"Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study","volume":"54","author":"De La Cruz","year":"2004","journal-title":"Pathol Int"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1440-1827.2011.02735.x","article-title":"Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma","volume":"61","author":"Ide","year":"2011","journal-title":"Pathol Int"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/tbj.12128","article-title":"Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma","volume":"19","author":"Gokce","year":"2013","journal-title":"Breast J"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ajcp\/73.3.313","article-title":"Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4): VI. Invasive papillary cancer","volume":"73","author":"Fisher","year":"1980","journal-title":"Am J Clin Pathol"},{"key":"R14-20230916","first-page":"660","article-title":"Invasive micropapillary carcinoma of the breast","volume":"6","author":"Siriaunkgul","year":"1993","journal-title":"Mod Pathol"},{"key":"R15-20230916","first-page":"116","article-title":"WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics","volume":"86","author":"B\u00f6cker","year":"2002","journal-title":"Verhandlungen der Deutschen Gesellschaft fur Pathologie"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12282-011-0330-1","article-title":"Influence of the in situ component in 389 infiltrating ductal breast carcinomas","volume":"20","author":"Carabias-Meseguer","year":"2013","journal-title":"Breast Cancer"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"484","DOI":"10.21037\/atm.2019.08.16","article-title":"The prognostic significance of co-existence ductal carcinoma in situ in invasive ductal breast cancer: a large population-based study and a matched case-control analysis","volume":"7","author":"Chen","year":"2019","journal-title":"Ann Transl Med"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/1066896907307047","article-title":"Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases","volume":"16","author":"Chen","year":"2008","journal-title":"Int J Surg Pathol"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0344-0338(96)80126-9","article-title":"Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas","volume":"192","author":"Luna-More","year":"1996","journal-title":"Pathol Res Pract"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"e106564","DOI":"10.1371\/journal.pone.0106564","article-title":"Similar prognoses for invasive micropapillary breast carcinoma and pure invasive ductal carcinoma: a retrospectively matched cohort study in China","volume":"9","author":"Liu","year":"2014","journal-title":"PloS One"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/bjc.2014.301","article-title":"Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast","volume":"111","author":"Chen","year":"2014","journal-title":"Br J Cancer"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.clbc.2015.01.008","article-title":"Differences in prognostic factors and failure patterns between invasive micropapillary carcinoma and carcinoma with micropapillary component versus invasive ductal carcinoma of the breast: retrospective multicenter case\u2013control study (KROG 13-06)","volume":"15","author":"Yu","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"R23-20230916","doi-asserted-by":"crossref","first-page":"e101390","DOI":"10.1371\/journal.pone.0101390","article-title":"Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China","volume":"9","author":"Shi","year":"2014","journal-title":"PLoS One"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.surg.2009.06.039","article-title":"Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis?","volume":"146","author":"Chagpar","year":"2009","journal-title":"Surgery"},{"key":"R25-20230916","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.breast.2014.01.015","article-title":"Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival","volume":"23","author":"Dieterich","year":"2014","journal-title":"Breast"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijsu.2019.01.016","article-title":"Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study","volume":"63","author":"Lopez Gordo","year":"2019","journal-title":"Int J Surg"},{"key":"R27-20230916","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12282-009-0192-y","article-title":"Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade","volume":"18","author":"Papantoniou","year":"2011","journal-title":"Breast Cancer"},{"key":"R28-20230916","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","article-title":"Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system","volume":"25","author":"Hudis","year":"2007","journal-title":"J Clin Oncol"},{"key":"R29-20230916","doi-asserted-by":"crossref","first-page":"38","DOI":"10.21037\/cco.2016.03.15","article-title":"Indications for adjuvant radiation therapy in breast cancer: a review of the evidence and recommendations for clinical practice","volume":"5","author":"Swanick","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"R30-20230916","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2559.1992.tb01032.x","article-title":"Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up","volume":"20","author":"Ellis","year":"1992","journal-title":"Histopathology"},{"key":"R31-20230916","first-page":"53","article-title":"WHO classification of tumors of the breast, 2012","volume":"75","author":"Frank","year":"2013","journal-title":"Arkh Patol"},{"key":"R32-20230916","first-page":"21","article-title":"Relationship between biologic behavior and morphologic features of invasive micropapillary carcinoma of the breast","volume":"33","author":"Fu","year":"2004","journal-title":"Zhonghua Bing Li Xue Za Zhi = Chin J Pathol"},{"key":"R33-20230916","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PAI.0000000000000167","article-title":"Invasive micropapillary carcinoma of the breast: immunophenotypic analysis and role of cell adhesion molecules (CD44 and E-cadherin) in nodal metastasis","volume":"24","author":"Badyal","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R34-20230916","doi-asserted-by":"crossref","first-page":"42455","DOI":"10.18632\/oncotarget.16405","article-title":"Clinicopathologic study of invasive micropapillary carcinoma of the breast","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"R35-20230916","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s12282-015-0653-4","article-title":"Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component","volume":"23","author":"Umeda","year":"2016","journal-title":"Breast Cancer"},{"key":"R36-20230916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-36362-8","article-title":"Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis","volume":"9","author":"Hao","year":"2019","journal-title":"Sci Rep"},{"key":"R37-20230916","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cam4.1227","article-title":"Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case\u2013control analysis","volume":"6","author":"Chen","year":"2017","journal-title":"Cancer Med"},{"key":"R38-20230916","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.18632\/oncotarget.22774","article-title":"Overexpression of \u03b21 integrin contributes to polarity reversal and a poor prognosis of breast invasive micropapillary carcinoma","volume":"9","author":"Liu","year":"2018","journal-title":"Oncotarget"},{"key":"R39-20230916","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40880-019-0406-4","article-title":"Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database","volume":"39","author":"Lewis","year":"2019","journal-title":"Cancer Commun"},{"key":"R40-20230916","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc2950","article-title":"What is the malignant nature of human ductal carcinoma in situ?","volume":"11","author":"Espina","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R41-20230916","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.bjc.6605655","article-title":"Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer","volume":"102","author":"Wong","year":"2010","journal-title":"Br J Cancer"},{"key":"R42-20230916","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00432-019-02930-2","article-title":"Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC\/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes","volume":"145","author":"Goh","year":"2019","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T04:07:54Z","timestamp":1694837274000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023487"}},"subtitle":["A retrospective cohort study"],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":42,"journal-issue":{"issue":"50","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023487","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,12,11]]}}}